Infrequent tumor initiative of the Children's Oncology Group: Initial lessons learned and their impact on future plans

Journal of Clinical Oncology

Volumn 28, Issue 33, 2010, Pages 5011-5016

  Pappo, Alberto S ^a   Krailo, Mark ^a   Chen, Zhengjia ^a   Rodriguez Galindo, Carlos ^a   Reaman, Gregory ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DACARBAZINE; INTERFERON; VINBLASTINE;

ADRENAL CORTEX CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RESEARCH; CLINICAL TRIAL (TOPIC); HEALTH INSURANCE; HUMAN; MEDICAL SOCIETY; MELANOMA; NASOPHARYNX CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; THYROID CARCINOMA;

ADOLESCENT; ADULT; CHILD; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; RHABDOMYOSARCOMA; SEER PROGRAM;

EID: 79951860892     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.2603     Document Type: Review

References (23)

1. Rare Disease Act of 2002: Public law act 107-280 November 6, 2002. http://history.nih.gov/ research/downloads/PL107-280.pdf
2. Ries L, Smith M, Gurney J, et al: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD, National Cancer Institute, SEER program Pub No 99-4649, 1999
3. Ferrari A, Bisogno G, De Salvo GL, et al: The challenge of very rare tumours in childhood: The Italian TREP project. Eur J Cancer 43:654-659, 2007 (Pubitemid 46502898)
4. International Classification of Childhood Cancer subgroup XI of the SEER database. http://seer .cancer.gov/csr/1975-2007/results-merged/sect-29- childhood-cancer-iccc.pdf
5. Bleyer WA: Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 38:1-10, 2002
6. Bleyer A, Budd T, Montello M: Adolescents and young adults with cancer: The scope of the problem and criticality of clinical trials. Cancer 107:1645-1655, 2006 (Pubitemid 44537071)
7. Bleyer A, O'Leary M, Barr R, et al: Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, MD, National Cancer Institute, National Institutes of Health, Pub. No. 06-5767, 2006
8. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2007 Sub (1973-2005) less than Katrina/Rita Population Adjustment more than - Linked To County Attributes - Total U.S., 1969 to 2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission. Bethesda, MD, National Cancer Institute, 2008
9. Liu L, Krailo M, Reaman GH, et al: Childhood cancer patients' access to cooperative group cancer programs: A population-based study. Cancer 97:1339-1345, 2003 (Pubitemid 36237322)
10. Pastore G, De Salvo GL, Bisogno G, et al: Evaluating access to pediatric cancer care centers of children and adolescents with rare tumors in Italy: The TREP project. Pediatr Blood Cancer 53:152-155, 2009
11. Ferrari A, Miceli R, Casanova M, et al: The symptom interval in children and adolescents with soft tissue sarcomas. Cancer 116:177-183, 2010
12. Dang-Tan T, Trottier H, Mery LS, et al: Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatric Blood & Cancer 51:468-474, 2008
13. DeNavas-Walt C, Proctor BD, Hill Lee C: Income, Poverty and Health Insurance Coverage in the United States: 2004. Washington, DC, US Census Bureau, 2005. http://www.census.gov/prod/ 2006pubs/p60-231.pd
14. Bleyer A, Barr R, Hayes-Lattin B, et al: The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8:288-298, 2008 (Pubitemid 351430865)
15. Institute of Medicine: http://www.nap.edu/ catalog/12,879.html
16. DiGiammarino EL, Lee AS, Cadwell C, et al: A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 9:12-16, 2002 (Pubitemid 34049172)
17. Ribeiro RC, Sandrini F, Figueiredo B, et al: An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 98:9330-9335, 2001 (Pubitemid 32743916)
18. Michalkiewicz E, Sandrini R, Figueiredo B, et al: Clinical and outcome characteristics of children with adrenocortical tumors: A report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 22:838-845, 2004 (Pubitemid 41103595)
19. Hill DA, Jarzembowski JA, Priest JR, et al: Type I pleuropulmonary blastoma: Pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 32:282-295, 2008 (Pubitemid 351172144)
20. Priest JR, Watterson J, Strong L, et al: Pleuropulmonary blastoma: A marker for familial disease. J Pediatr 128:220-224, 1996 (Pubitemid 26065946)
21. Hill DA, Ivanovich J, Priest JR, et al: DICER1 mutations in familial pleuropulmonary blastoma. Science 325:965, 2009
22. Strouse JJ, Fears TR, Tucker MA, et al: Pediatric melanoma: Risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 23:4735-4741, 2005 (Pubitemid 46224077)
23. Institute of Medicine: A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. http:// www.iom.edu/Reports/2010/A-National-Cancer-Clinical- Trials-System-for-the-21st- Century-Reinvigorating-the- NCI-Cooperative.aspx